America’s childhood obesity problem didn’t appear overnight, and it certainly won’t disappear because of a trendy new injection. Yet that seems to be where the conversation is heading. A growing debate is unfolding around the Trump administration’s “Make America Healthy Again” (MAHA) initiative and the increasing push to use GLP-1 drugs—medications like Ozempic and Wegovy—to…